Stacey Johnson
Stacey Johnson is the editor of Signals and a contributor. For 25 years, Stacey has been providing strategic communications counsel to government, corporate, technology and health organizations. She began her career at the CTV Television Network and then moved to Hill & Knowlton Canada where she advised clients in a variety of industries and sectors. Stacey is the Vice President, Communications and Marketing for CCRM, a leader in developing and commercializing regenerative medicine-based technologies and cell and gene therapies. She has a Master's degree in Public Relations. You can follow her on Twitter @msstaceyerin.
Posts by: Stacey
Right Turn: Remembering the warning signs of Alzheimer’s disease
. Alzheimer’s disease is a chronic, neurodegenerative disease characterized by loss of memory and changes in behaviour in the early stage. It typically starts slowly and progresses, within a decade, to death from an external factor, such as an infection or pneumonia, or the person’s body completely shuts down. According to the Alzheimer Society of […]
Right Turn: Video primer on stem cells better than a “Ruff” cut
. The Institute of Human Development, Child and Youth Health (IHDCYH), part of the Canadian Institutes of Health Research, is holding its IHDCYH Talks competition to feature research that falls within its mandate of improving knowledge translation and demonstrating the value of reproductive, child and youth health research in Canada. For this competition, participants were […]
Right Turn: Bands and bandages
. If you’ve never heard of epidermolysis bullosa (EB), you’re not alone. This rare genetic disease, which occurs in one of 20,000 births, creates fragile skin that tears at the slightest touch and results in blisters, sores and scar tissue. There is no cure. EB sufferers who are fortunate enough to survive into adulthood often […]
Luck is on their side in “bad luck” cancer study
. Before you read my blog, I recommend that you first read Sara Nolte’s blog “Bad luck, bad science, or bad reporting?” In it, Sara does an excellent job explaining and commenting on Drs. Cristian Tomasetti’s and Bert Vogelstein’s study “Variation in cancer risk among tissues can be explained by the number of stem cell […]